V
Versant Venture Management, LLC Portfolio Analytics
Investment Analysis & Holdings Breakdown
Comprehensive portfolio analytics for Versant Venture Management, LLC with $212.5M in long positions as of Q3 2025, 94% allocated to Healthcare, and 100% concentrated in top 10 positions.
- Portfolio Value
- $212.5M
- Top 10 Concentration
- 100%
- Top Sector
- Healthcare (94%)
- US Exposure
- 93%
- Market Cap Focus
- Small Cap
- Countries
- 3
Composition Analysis
Portfolio breakdown by sector, industry, and market capitalization
Sector Allocation
Industry Breakdown
1 industry across all sectors
Filter by Sector
Select a sector to filter industries
Market Cap Distribution
Portfolio Concentration
Geographic Exposure
Portfolio breakdown by country of incorporation
Domestic (US)
International
Countries
Largest Int'l Market
Holding Behavior
Investment patterns and position management analysis
Portfolio Stability & Commitment
- Avg. Top 10
- 8.8 quarters
- Avg. Top 20
- 8.8 quarters
- Avg. All Positions
- 8.8 quarters
- Median Holding Period
- 5 quarters
- Persistence Rate
- 55.56%
- Persistent Holdings Weight
- 14.53%
- Persistent Positions
- 5
- Longest Held
CRISPR Therapeutics AGCRSP - 30 quarters
Position Sizing & Influence
Current Quarter
- Avg. New Position
- 58.25%
- Avg. Position Weight
- 11.11%
- Largest Position
LENZ Therapeutics, Inc. Common StockLENZ - 58.25%- Largest Ownership Stake
- LENZ Therapeutics, Inc. Common StockLENZ - 9.32%
- Avg. Ownership Stake
- 7.83%
- Ownership Stake >5%
- 4
- Ownership Stake >1%
- 7
Historical (Since Q4 2014)
- Avg. New Position
- 20.45%
- Avg. Ownership Stake
- 3.91%
- Largest Position
- RYZBRayzeBio, Inc. Common StockRYZB - 82.47% (Q4 2023)
- Largest Ownership Stake
- LENZ Therapeutics, Inc. Common StockLENZ - 9.32% (Q3 2025)
Portfolio Turnover
No data available